Inspira Technologies Oxy B.H.N. Ltd. – NASDAQ:IINN

Add to watchlist

$1.27

+0.20

+19.81%

Market closed

Open in 2 days

-17.83%

month

-17.83%

quarter

-8.62%

year

Market Cap	16.85M
Enterprise value	8.90M

P/E	-1.34
EV/Sales	N/A
EV/EBITDA	-0.58
Price/Sales	N/A
Price/Book	0.91
PEG ratio	N/A
EPS	-0.87

Revenue	N/A
EBITDA	-11.43M
Income	-10.91M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Profit margin
Mar 2023	0	-2.66M
Jun 2023	0	-2.82M
Sep 2023	0	-2.42M
Dec 2023	0	-3.00M

Inspira Technologies Oxy B.H.N. Ltd. Financials Estimate

Q Y

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Analyst Estimates
2025	26.49M	-7.44M	-28.11%

Analysts Price target
Financials & Ratios estimates

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Earnings per share (EPS)
2023-08-10	-0.32	-0.23546
2023-11-16	-0.3	-0.22
2024-04-08	-0.29	-0.17

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Debt to assets
Mar 2023	13408000	3.32M	24.82%
Jun 2023	10840000	3.28M	30.33%
Sep 2023	8163000	2.99M	36.68%
Dec 2023	9310000	3.57M	38.37%

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Cash Flow
Mar 2023	0	0	0
Jun 2023	1.01K	0	0
Sep 2023	0	0	0
Dec 2023	0	0	0

Inspira Technologies Oxy B.H.N. Ltd. alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Inspira Technologies Oxy B.H.N. Ltd.
Employees

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN): Employee count
Aug 2023	32
Sep 2023	32
Oct 2023	32
Nov 2023	32
Dec 2023	32
Jan 2024	32
Feb 2024	32
Mar 2024	32
Apr 2024	32
May 2024	37
Jun 2024	37
Jul 2024	37

Inspira Technologies Oxy B.H.N. Ltd.
Hedge Funds Holdings Q1 2023

1.36% +1.05%

of IINN is owned by hedge funds

2 +1

hedge funds hold IINN stock

72.14K +55.67K

shares is hold by hedge funds

IINN hedge funds holdings changes

Inspira Technologies Oxy B.H.N. Ltd.
Latest News

Friday, 27 December 2024
10:09	Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company	prnewswire.com
Monday, 16 December 2024
08:30	Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment	prnewswire.com
Tuesday, 10 December 2024
08:00	Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions	prnewswire.com
Wednesday, 4 December 2024
07:00	Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios	prnewswire.com
Friday, 8 November 2024
09:11	Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11	prnewswire.com
Thursday, 24 October 2024
08:30	Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100	prnewswire.com
Wednesday, 9 October 2024
08:00	Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism	prnewswire.com
Wednesday, 25 September 2024
14:30	Inspira Stock to Gain From its Appearance at Annual ELSO Conference	zacks.com
Tuesday, 24 September 2024
08:30	Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference	prnewswire.com
Monday, 16 September 2024
09:01	IINN Stock Gains on Second US Patent Approval for VORTX System	zacks.com
Friday, 13 September 2024
07:30	Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System	prnewswire.com
Monday, 2 September 2024
09:00	Favorable Clinical Results for HYLA Sensor Might Boost Inspira Stock	zacks.com
Wednesday, 28 August 2024
08:45	Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024	prnewswire.com
Friday, 23 August 2024
12:41	INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare	zacks.com
Thursday, 22 August 2024
08:00	Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product	prnewswire.com
Tuesday, 13 August 2024
08:00	Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow	prnewswire.com
Tuesday, 30 July 2024
07:30	Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest	prnewswire.com
Thursday, 11 July 2024
08:30	Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System	prnewswire.com
Friday, 21 June 2024
12:16	Inspira (IINN) Unveils Business Targets for 2024-25	zacks.com
Thursday, 20 June 2024
09:25	Inspira™ Announces Business Plan Targets	prnewswire.com
Monday, 17 June 2024
08:30	Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel	prnewswire.com
Thursday, 13 June 2024
08:30	Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.	prnewswire.com
Wednesday, 5 June 2024
08:30	Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector	prnewswire.com
Thursday, 30 May 2024
08:30	Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments	prnewswire.com
Wednesday, 29 May 2024
13:16	Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant	zacks.com
Tuesday, 28 May 2024
09:25	INSPIRA™ ART100 Receives FDA 510(k) Clearance	prnewswire.com
Thursday, 2 May 2024
09:18	Inspira™ Announces Start of Production of the INSPIRA™ ART100	prnewswire.com
Thursday, 25 April 2024
08:00	Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100	prnewswire.com
Tuesday, 16 April 2024
08:42	Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures	prnewswire.com
Wednesday, 10 April 2024
08:24	Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections	prnewswire.com

Frequently Asked Questions (FAQ)

What's the price of Inspira Technologies Oxy B.H.N. Ltd. stock today?

One share of Inspira Technologies Oxy B.H.N. Ltd. stock can currently be purchased for approximately $1.27.
When is Inspira Technologies Oxy B.H.N. Ltd.'s next earnings date?

Unfortunately, Inspira Technologies Oxy B.H.N. Ltd.'s (IINN) next earnings date is currently unknown.
Does Inspira Technologies Oxy B.H.N. Ltd. pay dividends?

No, Inspira Technologies Oxy B.H.N. Ltd. does not pay dividends.
How much money does Inspira Technologies Oxy B.H.N. Ltd. make?

Inspira Technologies Oxy B.H.N. Ltd. has a market capitalization of 16.85M. Inspira Technologies Oxy B.H.N. Ltd. made a loss 11.29M US dollars in net income (profit) last year or -$0.17 on an earnings per share basis.
What is Inspira Technologies Oxy B.H.N. Ltd.'s stock symbol?

Inspira Technologies Oxy B.H.N. Ltd. is traded on the NASDAQ under the ticker symbol "IINN".
What is Inspira Technologies Oxy B.H.N. Ltd.'s primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Inspira Technologies Oxy B.H.N. Ltd.?

Shares of Inspira Technologies Oxy B.H.N. Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Inspira Technologies Oxy B.H.N. Ltd. have?

As Jul 2024, Inspira Technologies Oxy B.H.N. Ltd. employs 37 workers, which is 16% more then previous quarter.
When Inspira Technologies Oxy B.H.N. Ltd. went public?

Inspira Technologies Oxy B.H.N. Ltd. is publicly traded company for more then 4 years since IPO on 14 Jul 2021.
What is Inspira Technologies Oxy B.H.N. Ltd.'s official website?

The official website for Inspira Technologies Oxy B.H.N. Ltd. is inspira-technologies.com.
How can i contact Inspira Technologies Oxy B.H.N. Ltd.?

Inspira Technologies Oxy B.H.N. Ltd. can be reached via phone at +972 9 966 4488.

Inspira Technologies Oxy B.H.N. Ltd.

inspira-technologies.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Devices

Sector:

Healthcare

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

+972 9 966 4488

2 Ha-Tidhar Street
Raanana, 4366504

CIK: 0001837493
ISIN: IL0011715781
CUSIP: M53637100